Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1Pancreatic Neoplasms 1Keratosis, Actinic 1Breast Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 280Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × perillyl alcohol × Clear all
NCT00003219 2019-12-13

Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer

University of Wisconsin, Madison

Phase 2 Completed
Breast

Breast Neoplasms

NCT00003238 2019-12-13

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

University of Wisconsin, Madison

Phase 2 Completed
Genitourinary

Prostatic Neoplasms

NCT00608634 2015-04-01

Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses

University of Arizona

Phase 2 Completed
89 enrolled 10 charts
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

NCT00003769 2014-09-10

Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer

Indiana University

Phase 2 Completed
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡